EP1303287A4 - Mhc peptides over-expressed on prostate cancer cells and methods of use - Google Patents
Mhc peptides over-expressed on prostate cancer cells and methods of useInfo
- Publication number
- EP1303287A4 EP1303287A4 EP01942207A EP01942207A EP1303287A4 EP 1303287 A4 EP1303287 A4 EP 1303287A4 EP 01942207 A EP01942207 A EP 01942207A EP 01942207 A EP01942207 A EP 01942207A EP 1303287 A4 EP1303287 A4 EP 1303287A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- expressed
- methods
- cancer cells
- prostate cancer
- peptides over
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21221300P | 2000-06-16 | 2000-06-16 | |
US21216500P | 2000-06-16 | 2000-06-16 | |
US212165P | 2000-06-16 | ||
US212213P | 2000-06-16 | ||
PCT/US2001/019207 WO2001097827A1 (en) | 2000-06-16 | 2001-06-15 | Mhc peptides over-expressed on prostate cancer cells and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1303287A1 EP1303287A1 (en) | 2003-04-23 |
EP1303287A4 true EP1303287A4 (en) | 2006-02-08 |
Family
ID=26906839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01942207A Withdrawn EP1303287A4 (en) | 2000-06-16 | 2001-06-15 | Mhc peptides over-expressed on prostate cancer cells and methods of use |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1303287A4 (en) |
AU (1) | AU2001275490A1 (en) |
WO (1) | WO2001097827A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE385503T1 (en) * | 1999-06-28 | 2008-02-15 | Inter K Pty Ltd | METHOD FOR MODULATING INTEGRIN-MEDIATED CELL ACTIVITY AND REAGENTS SUITABLE FOR THIS |
AUPR230500A0 (en) | 2000-12-22 | 2001-01-25 | University Of Newcastle Research Associates Limited, The | A method of modulating map kinase mediated cellular activity and agents useful in same |
US20100233176A1 (en) * | 2008-10-06 | 2010-09-16 | Cashman Neil R | Methods and systems for predicting misfolded protein epitopes |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998033888A1 (en) * | 1997-01-31 | 1998-08-06 | Epimmune, Inc. | Peptides and peptide-loaded antigen presenting cells for the activation of ctl |
US5846810A (en) * | 1994-10-28 | 1998-12-08 | Kyowa Hakko Kogyo Co. Ltd. | Human 26S proteasome subunit components |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990002564A1 (en) * | 1988-09-12 | 1990-03-22 | Codon | Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi |
-
2001
- 2001-06-15 WO PCT/US2001/019207 patent/WO2001097827A1/en not_active Application Discontinuation
- 2001-06-15 AU AU2001275490A patent/AU2001275490A1/en not_active Abandoned
- 2001-06-15 EP EP01942207A patent/EP1303287A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846810A (en) * | 1994-10-28 | 1998-12-08 | Kyowa Hakko Kogyo Co. Ltd. | Human 26S proteasome subunit components |
WO1998033888A1 (en) * | 1997-01-31 | 1998-08-06 | Epimmune, Inc. | Peptides and peptide-loaded antigen presenting cells for the activation of ctl |
Non-Patent Citations (4)
Title |
---|
CORREALE P ET AL: "Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 161, 1998, pages 3186 - 3194, XP002975760, ISSN: 0022-1767 * |
SCHMIDT WALTER ET AL: "Cell-free tumor antigen peptide-based cancer vaccines", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 94, no. 7, 1997, pages 3262 - 3267, XP002168512, ISSN: 0027-8424 * |
See also references of WO0197827A1 * |
TJOA B A ET AL: "PROGRESS IN ACTIVE SPECIFIC IMMUNOTHERAPY OF PROSTATE CANCER", SEMINARS IN SURGICAL ONCOLOGY, vol. 18, no. 1, 2000, pages 80 - 87, XP000915524, ISSN: 8756-0437 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001097827A1 (en) | 2001-12-27 |
EP1303287A1 (en) | 2003-04-23 |
AU2001275490A1 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3619400A (en) | Human prostate cancer associated gene sequences and polypeptides | |
HK1038512A1 (en) | Methods of inducing cancer cell death and tumor regression | |
AU7924501A (en) | Progenitor cells and methods and uses related thereto | |
HUP0203968A3 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU8026600A (en) | Brachytherapy instrument and methods | |
AU2003217304A1 (en) | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy | |
AU2001278070A1 (en) | Basal cell markers in breast cancer and uses thereof | |
HUP0002095A3 (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
IL153970A0 (en) | Promyostatin peptides and methods of using same | |
EP0926955A4 (en) | Conjugates useful in the treatment of prostate cancer | |
EP1319178A4 (en) | Method of identifying cancer markers and uses therefor in the diagnosis of cancer | |
EP1404366A4 (en) | Combination therapy of gamma-interferon and b cell specific antibodies | |
HUP0000651A3 (en) | Conjugates useful in the treatment of prostate cancer | |
IL206604A0 (en) | Transmembrane protein expressed in prostate cancer | |
AU2002243314A1 (en) | Immunogenic cancer peptides and uses thereof | |
EP1303287A4 (en) | Mhc peptides over-expressed on prostate cancer cells and methods of use | |
EP1316560A4 (en) | Novel human cancer/testis antigen and gene thereof | |
WO2003026494A3 (en) | Galectins-1-and-4 in tumor development | |
PL371202A1 (en) | Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine | |
IL148323A0 (en) | Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal | |
AU2002227272A1 (en) | Ovarian tumor antigen and methods of use therefor | |
GB9812550D0 (en) | Tumour therapy and imaging | |
AU7832700A (en) | Ovarian tumor antigen and methods of use therefor | |
IL132531A0 (en) | Detection and therapy of tumors | |
PL357906A1 (en) | Combination of carboxyalkylethers with antihypertensives and pharmaceutical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030116 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07K 14/47 B Ipc: 7C 12N 5/08 B Ipc: 7C 12N 5/06 B Ipc: 7C 07K 16/00 B Ipc: 7C 07K 7/00 B Ipc: 7A 01N 63/00 B Ipc: 7A 61K 39/00 B Ipc: 7A 61K 39/395 B Ipc: 7A 61K 38/04 B Ipc: 7A 61K 38/00 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20051223 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060715 |